Media Summary: Experts in colorectal cancer explore the use of Still have questions about hereditary cancer Corrie Painter, Ph.D., and Eliezer Van Allen, M.D., discuss the current state of

Case 1 Genomic Testing Nccn - Detailed Analysis & Overview

Experts in colorectal cancer explore the use of Still have questions about hereditary cancer Corrie Painter, Ph.D., and Eliezer Van Allen, M.D., discuss the current state of Emmanuel S. Antonarakis, MBBCh, an associate professor of oncology at Johns Hopkins Medicine, discussed updated NationalĀ ... Emmanuel S. Antonarakis, MD, associate professor of oncology, John Hopkins University, discusses the updates from the Speakers: Shazia Mahamdallie and Dr. Dahlia Hopmeier In the episode we explain the basics of genes,

PREVIOUSLY RECORDED: August 20, 2025 Exome and

Photo Gallery

Case 1: Genomic Testing & NCCN Guidelines for Metastatic CRC
NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)
Genetic Testing for Prostate Cancer | NCCN Guidelines
2021 FORCE | Hereditary Cancer | Hereditary Cancer Genetics, Risk and Management Q&A Panel
Understanding Genomics and Genetic Testing in Cancer Immunotherapy
Incorporating Genomic Testing For Prostate Cancer into Your Practice (2021)
NCCN Guidelines for Genetic Testing in Prostate Cancer
Reviewing NCCN Recommendations for Genetic Testing in Prostate Cancer
Think of genomic testing like building a PC
Series 1 Episode 1:  Genomic testing in the NHS
First Line Genomic Testing: What New AAP Guidance Means for Pediatricians
What are the NCCN guidelines?
Sponsored
Sponsored
View Detailed Profile
Case 1: Genomic Testing & NCCN Guidelines for Metastatic CRC

Case 1: Genomic Testing & NCCN Guidelines for Metastatic CRC

Experts in colorectal cancer explore the use of

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)

Excerpt from the July 2025 ICARE

Sponsored
Genetic Testing for Prostate Cancer | NCCN Guidelines

Genetic Testing for Prostate Cancer | NCCN Guidelines

Genetic testing

2021 FORCE | Hereditary Cancer | Hereditary Cancer Genetics, Risk and Management Q&A Panel

2021 FORCE | Hereditary Cancer | Hereditary Cancer Genetics, Risk and Management Q&A Panel

Still have questions about hereditary cancer

Understanding Genomics and Genetic Testing in Cancer Immunotherapy

Understanding Genomics and Genetic Testing in Cancer Immunotherapy

Corrie Painter, Ph.D., and Eliezer Van Allen, M.D., discuss the current state of

Sponsored
Incorporating Genomic Testing For Prostate Cancer into Your Practice (2021)

Incorporating Genomic Testing For Prostate Cancer into Your Practice (2021)

Incorporating

NCCN Guidelines for Genetic Testing in Prostate Cancer

NCCN Guidelines for Genetic Testing in Prostate Cancer

Emmanuel S. Antonarakis, MBBCh, an associate professor of oncology at Johns Hopkins Medicine, discussed updated NationalĀ ...

Reviewing NCCN Recommendations for Genetic Testing in Prostate Cancer

Reviewing NCCN Recommendations for Genetic Testing in Prostate Cancer

Emmanuel S. Antonarakis, MD, associate professor of oncology, John Hopkins University, discusses the updates from the

Think of genomic testing like building a PC

Think of genomic testing like building a PC

Think of

Series 1 Episode 1:  Genomic testing in the NHS

Series 1 Episode 1: Genomic testing in the NHS

Speakers: Shazia Mahamdallie and Dr. Dahlia Hopmeier In the episode we explain the basics of genes,

First Line Genomic Testing: What New AAP Guidance Means for Pediatricians

First Line Genomic Testing: What New AAP Guidance Means for Pediatricians

PREVIOUSLY RECORDED: August 20, 2025 Exome and

What are the NCCN guidelines?

What are the NCCN guidelines?

The

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)

Excerpt from the November 2025 ICARE